ArticleClinical and molecular hepatology2026

Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancer.

Daeseong Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.